196 related articles for article (PubMed ID: 29526547)
1. Huntingtin protein: A new option for fixing the Huntington's disease countdown clock.
Caterino M; Squillaro T; Montesarchio D; Giordano A; Giancola C; Melone MAB
Neuropharmacology; 2018 Jun; 135():126-138. PubMed ID: 29526547
[TBL] [Abstract][Full Text] [Related]
2. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
[TBL] [Abstract][Full Text] [Related]
3. The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.
Wanker EE; Ast A; Schindler F; Trepte P; Schnoegl S
J Neurochem; 2019 Nov; 151(4):507-519. PubMed ID: 31418858
[TBL] [Abstract][Full Text] [Related]
4. N-alpha-acetylation of Huntingtin protein increases its propensity to aggregate.
Gottlieb L; Guo L; Shorter J; Marmorstein R
J Biol Chem; 2021 Dec; 297(6):101363. PubMed ID: 34732320
[TBL] [Abstract][Full Text] [Related]
5. Cancer: From Wild-Type to Mutant Huntingtin.
Thion MS; Humbert S
J Huntingtons Dis; 2018; 7(3):201-208. PubMed ID: 29889077
[TBL] [Abstract][Full Text] [Related]
6. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.
Arbez N; Ratovitski T; Roby E; Chighladze E; Stewart JC; Ren M; Wang X; Lavery DJ; Ross CA
J Biol Chem; 2017 Nov; 292(47):19238-19249. PubMed ID: 28972180
[TBL] [Abstract][Full Text] [Related]
8. Huntington's Disease Protein Huntingtin Associates with its own mRNA.
Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N
J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
[TBL] [Abstract][Full Text] [Related]
10. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
11. Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease.
Skogen M; Roth J; Yerkes S; Parekh-Olmedo H; Kmiec E
BMC Neurosci; 2006 Oct; 7():65. PubMed ID: 17014717
[TBL] [Abstract][Full Text] [Related]
12. How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.
Lontay B; Kiss A; Virág L; Tar K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560122
[TBL] [Abstract][Full Text] [Related]
13. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
14. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
[TBL] [Abstract][Full Text] [Related]
15. Huntington's Disease-An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components.
Taran AS; Shuvalova LD; Lagarkova MA; Alieva IB
Cells; 2020 Jun; 9(6):. PubMed ID: 32580314
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways.
Moily NS; Ormsby AR; Stojilovic A; Ramdzan YM; Diesch J; Hannan RD; Zajac MS; Hannan AJ; Oshlack A; Hatters DM
Mol Cell Neurosci; 2017 Sep; 83():103-112. PubMed ID: 28743452
[TBL] [Abstract][Full Text] [Related]
17. A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease.
Martin DDO; Kay C; Collins JA; Nguyen YT; Slama RA; Hayden MR
Sci Rep; 2018 May; 8(1):8096. PubMed ID: 29802276
[TBL] [Abstract][Full Text] [Related]
18. Is Huntingtin Dispensable in the Adult Brain?
Liu JP; Zeitlin SO
J Huntingtons Dis; 2017; 6(1):1-17. PubMed ID: 28339401
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems.
Harding RJ; Loppnau P; Ackloo S; Lemak A; Hutchinson A; Hunt B; Holehouse AS; Ho JC; Fan L; Toledo-Sherman L; Seitova A; Arrowsmith CH
J Biol Chem; 2019 Apr; 294(17):6986-7001. PubMed ID: 30842263
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
Arndt JR; Chaibva M; Legleiter J
Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
